71/100
overall score
Total issues found:
392276Updated on: November 26, 2024
Data we analyse
Phishing and malware
392011
issues
Network security
5
issues
Email security
0
issues
Website security
260
issues
Recent critical risk issues we found
239 corporate credentials stolen
24% employees reuse breached passwords
250 SSL configuration issues found
What information we check
Software patching
Web application security
Email security
Dark web exposure
Cybersecurity Benchmark
A comparison of this company’s cybersecurity ranking with industry averages and peer organizations
Phishing and malware
0
vs.
41
Network security
99
vs.
91
Email security
100
vs.
71
Website security
63
vs.
65
Get Your Free Report
Need help in fixing issues? Contact us and we will help you prepare an action plan to improve your risk rating.
Company overview
Novartis is a global, research-driven healthcare company headquartered in Basel, Switzerland, that develops, manufactures and markets innovative prescription medicines as well as generics and biosimilars through its Sandoz division. With core expertise across oncology, immunology, neuroscience, rare diseases and advanced cell and gene therapies, Novartis combines large-scale manufacturing capabilities with intensive R&D and strategic partnerships to bring therapies to market worldwide. For more information, see novartis.com.
Details
Website:
Industries:
Manufacturing
Company size:
10,001+ employees
Founded:
-
Headquarters:
Novartis Campus; Basel, Baselstadt 4002, CH
Outcome reliability
We analyze billions of signals from publicly available sources to deliver validated insights into how your company is perceived externally by threat actors. These insights help security teams respond more quickly to risks, manage zero-day incidents effectively, and reduce overall exposure.
